Appeals court re-restricts mail-order abortion drugs

The Fifth Circuit Court of Appeals suspended a Food and Drug Administration policy from the Biden presidency that allows suppliers to mail mifepristone without prior consent from a physician. Mifepristone is the main drug used in abortion pills. In 2023, United States President Joe Biden removed the restriction on women requiring an examination by a physician before they could order the drug. This effectively allowed mail-in abortions on demand, despite mifepristone being linked to problems like sepsis. The recent verdict does not suspend the drug from being sent out, but at least it restores some barrier to women being able to kill their unborn babies on demand.